EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Association of Arylacetamide Deacetylase-Mediated Extracellular Matrix Remodeling With Immune Exclusion in Pancreatic Cancer

Chao Wu, Jun Yang

World Journal of Oncology · 2026-06 · 17 (3) · 347-356

DOI: 10.14740/wjon2727 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Oncology, 2026-06. Verfasst von Chao Wu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Xuzhou Medical University, Xuzhou, Jiangsu 221000, China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

AADACCD8+ T-cell distributionCOL6A1Integrin signalingPDAC

Autor:innen und Institutionen

  • Department of General Surgery, Xuzhou Medical University, Xuzhou, Jiangsu 221000, China.
  • Department of General Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221000, China.

Zitieren

APA

Wu, C., & Yang, J. (2026). Association of Arylacetamide Deacetylase-Mediated Extracellular Matrix Remodeling With Immune Exclusion in Pancreatic Cancer. World Journal of Oncology, 17(3), 347-356. https://doi.org/10.14740/wjon2727

Vancouver

Wu C, Yang J. Association of Arylacetamide Deacetylase-Mediated Extracellular Matrix Remodeling With Immune Exclusion in Pancreatic Cancer. World Journal of Oncology. 2026;17(3):347-356. doi:10.14740/wjon2727

BibTeX
@article{Wu2026,
  author = {Wu, Chao and Yang, Jun},
  title = {Association of Arylacetamide Deacetylase-Mediated Extracellular Matrix Remodeling With Immune Exclusion in Pancreatic Cancer},
  journal = {World Journal of Oncology},
  year = {2026},
  volume = {17},
  number = {3},
  pages = {347--356},
  doi = {10.14740/wjon2727}
}
Kostenlos starten →